Some Added Hope For Dendreon
Dendreon Corporation (NASDAQ: DNDN) needs all the goods news it can get. While the American Society for Clinical Oncology (ASCO) has its annual meeting in les than two weeks and ...Read Full Story »
Posts related to ‘Biotech’
Read Full Story »
An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...Read Full Story »
Dendreon In Trouble
Dendreon Corporation (NASDAQ: DNDN) is in trouble. That is what the performance is telling investors. The maker of Provenge as a late-stage prostate cancer treatment has three issues working against ...Read Full Story »
IPO Filing From KYTHERA: Fighting The Double Chin
KYTHERA Biopharmaceuticals, Inc. has just joined in with the companies which have filed to come public via an initial public offering. The common stock plans to be listed on The ...Read Full Story »
Rosetta Genomics Share Offering: No Good Deeds Go Unpunished
Rosetta Genomics, Ltd. (NASDAQ: ROSG) was an exponential winner on Wednesday due to getting a Medicare reimbursement ruling in its favor. The company had announced that the Medicare Administrative Contractor ...Read Full Story »
Rosetta Genomics Joins Exponential Explosion Club on Medicare Coverage
Rosetta Genomics Ltd. (NASDAQ: ROSG) is not often in the news, but it is in the news a big way now. The microRNA-based molecular diagnostic test maker has announced that Novitas, ...Read Full Story »
NASDAQ Changes Up Biotech Index Members & Weightings
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added and deleted from them as money management firms often buy and ...Read Full Story »
Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)
Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be. It often traded huge volume around drug approval or study news, and shares ...Read Full Story »
Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)
It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. ...Read Full Story »
Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech ...Read Full Story »
Dendreon, When 200% Sales Growth Is Not Enough (DNDN)
Dendreon Corporation (NASDAQ: DNDN) has reported its quarterly results and the reaction is a bit cool. This is growth of almost 200%, as net product revenue for the quarter was ...Read Full Story »
Vertex Sees Billions In Value on Cystic Fibrosis Results (VRTX)
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is trading up so much higher that you might think the company is being acquired. The real reason for the huge share gains is based ...Read Full Story »
Second Look: Is There Any Real Value Left In Savient? (SVNT, DNDN, SVNT)
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) already had problems before a fund called Tang Capital accused it of being insolvent this week. Over the last year this stock has fallen down ...Read Full Story »
One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the biggest public merger rumors out there. At least that is the belief ...Read Full Story »
Amylin Gets Carl Icahn Off Its Neck! (AMLN, IEP)
Amylin Pharmaceuticals, Inc. (AMLN) is supposed to be getting a takeover offer soon, or at least it is expected to receive or disclose several possible bids soon. Now the company ...Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (3376)
- Accounting (283)
- Activist Investor (250)
- ADR (534)
- Aerospace (111)
- After-Hours Activity (98)
- Agriculture (260)
- Airlines (303)
- Analyst Calls (2698)
- Annual Report (63)
- Apparel (208)
- Austerity (33)
- auto (15)
- Autos (1162)
- Bait Shop (91)
- Banking (1663)
- Bankruptcy (202)
- Biotech (726)
- Blogs (5)
- Bonds (384)
- Brokerage Firms (437)
- Buffett (301)
- Buffett Holdings (31)
- business and finance (27)
- Business Services (177)
- Cable Companies (128)
- Calendar (226)
- Casinos (67)
- Charts (107)
- China (857)
- Commodities (636)
- Compensation (309)
- Conglomerates (424)
- Consumer Electronics (1098)
- Consumer Goods (502)
- Corporate Governance (491)
- Cramer (728)
- Cult Stock (191)
- Currency (127)
- Defense (75)
- Defensive Stocks (116)
- Dividend (512)
- Drug companies (276)
- Earnings (2938)
- Earnings Warning (447)
- Economy (2465)
- Editor's Picks (458)
- Emerging Markets (195)
- Entertainment (570)
- ETF (532)
- Exchange (43)
- Exchange News (121)
- FDA (90)
- Financial Stocks (1182)
- Food (592)
- General (3668)
- Green Biz (878)
- Alternative Energy (838)
- Hardware (207)
- Healthcare (173)
- HI/LOW (711)
- Housing (679)
- Index (288)
- Industry (157)
- Technology (117)
- Semiconductors (38)
- Technology (117)
- Infrastructure (197)
- Insider Activity (217)
- International Markets (2079)
- Internet (1720)
- Interview (53)
- IPOs (998)
- Labor & Unions (451)
- Large Cap Stocks (129)
- Law (404)
- Luxury (156)
- Management Change (629)
- Market Close (159)
- Market Open (191)
- Market Roundups (40)
- Media (861)
- Medical (238)
- Mergers and Buy Outs (1867)
- Metals (460)
- Micro Cap (7)
- Most Actives (31)
- Mutual Funds (224)
- Nanotech (8)
- Newsletter (7)
- Nuclear (74)
- Oil & Gas (1855)
- Old Media (206)
- Options (106)
- OTC (25)
- PC Companies (613)
- Personal Finance (79)
- Pharmaceuticals (227)
- Politics (567)
- Polls (23)
- Pre-Market Activity (757)
- Press Digest (1350)
- Private Equity (432)
- Product Review (62)
- Regulation (472)
- REIT (89)
- Research (1586)
- Restatements (23)
- Retail (1255)
- Rumors (876)
- Satellite (273)
- SEC (164)
- Secondary Offering (529)
- Semiconductor (638)
- Shareholder Issues (475)
- Short Interest (326)
- Small Cap Stocks (20)
- Software (766)
- Special Report (125)
- Stock Buybacks (173)
- Stock Splits (60)
- Tax (86)
- Technical Analysis (99)
- Technology Companies (1340)
- Telecom (657)
- The Day (84)
- The Week (148)
- Tobacco (47)
- Trading Alert (960)
- Transports (250)
- Turnarounds (210)
- TV (86)
- Utilities (283)
- Value Investing (330)
- Video Games (204)
- Water (55)
- WiMAX (164)
- Wireless (966)
